Literature DB >> 19879595

The effects of lactulose supplementation to enteral feedings in premature infants: a pilot study.

Arieh Riskin1, Ori Hochwald, David Bader, Isaac Srugo, Gabi Naftali, Amir Kugelman, Ella Cohen, Frida Mor, Bela Kaufman, Ron Shaoul.   

Abstract

OBJECTIVE: To assess the safety and prebiotic effects of lactulose in preterm infants. STUDY
DESIGN: This was a prospective, double-blinded, placebo-controlled, single-center study in 23- to 34-weeks premature infants. The study group received 1% lactulose, and control infants received 1% dextrose in all feeds (human milk or formula).
RESULTS: Twenty-eight infants participated (15 lactulose, 13 placebo). Small doses of lactulose appeared to be safe and did not cause diarrhea. Premature infants on lactulose had more Lactobacilli-positive stool cultures that appeared earlier with larger number of colonies. The lactulose group tended to have less intolerance to enteral feedings, to reach full oral feeds earlier, and to be discharged home earlier. They also tended to have fewer episodes of late-onset sepsis, lower Bell stage necrotizing enterocolitis, and their nutritional laboratory indices were better, especially calcium and total protein.
CONCLUSIONS: This pilot study supports the safety of supplementing preterm infants' feeds with low doses of lactulose. It also demonstrated trends that may suggest positive prebiotic effects. Copyright 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19879595     DOI: 10.1016/j.jpeds.2009.09.006

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

Review 1.  Prevention of Necrotizing Enterocolitis Through Manipulation of the Intestinal Microbiota of the Premature Infant.

Authors:  Kannikar Vongbhavit; Mark A Underwood
Journal:  Clin Ther       Date:  2016-02-09       Impact factor: 3.393

2.  Prebiotics for the prevention of hyperbilirubinaemia in neonates.

Authors:  Amir Mohammad Armanian; Shayesteh Jahanfar; Awat Feizi; Nima Salehimehr; Mitra Molaeinezhad; Erfan Sadeghi
Journal:  Cochrane Database Syst Rev       Date:  2019-08-13

Review 3.  Microbial therapeutic interventions.

Authors:  Nicole G Grady; Elaine O Petrof; Erika C Claud
Journal:  Semin Fetal Neonatal Med       Date:  2016-04-25       Impact factor: 3.926

4.  An update on necrotizing enterocolitis: pathogenesis and preventive strategies.

Authors:  Jang Hoon Lee
Journal:  Korean J Pediatr       Date:  2011-09-30

5.  The Effect of Neutral Oligosaccharides on Reducing the Incidence of Necrotizing Enterocolitis in Preterm infants: A Randomized Clinical Trial.

Authors:  Amir-Mohammad Armanian; Alireza Sadeghnia; Maryam Hoseinzadeh; Maryam Mirlohi; Awat Feizi; Nima Salehimehr; Najme Saee; Jila Nazari
Journal:  Int J Prev Med       Date:  2014-11

6.  The effect of neutral oligosaccharides on fecal microbiota in premature infants fed exclusively with breast milk: A randomized clinical trial.

Authors:  Amir-Mohammad Armanian; Alireza Sadeghnia; Maryam Hoseinzadeh; Maryam Mirlohi; Awat Feizi; Nima Salehimehr; Moloud Torkan; Zahra Shirani
Journal:  J Res Pharm Pract       Date:  2016 Jan-Mar

7.  Effects of prebiotics on sepsis, necrotizing enterocolitis, mortality, feeding intolerance, time to full enteral feeding, length of hospital stay, and stool frequency in preterm infants: a meta-analysis.

Authors:  Cheng Chi; Nicholas Buys; Cheng Li; Jing Sun; Chenghong Yin
Journal:  Eur J Clin Nutr       Date:  2018-12-19       Impact factor: 4.016

Review 8.  Probiotics, prebiotics infant formula use in preterm or low birth weight infants: a systematic review.

Authors:  Mary N Mugambi; Alfred Musekiwa; Martani Lombard; Taryn Young; Reneé Blaauw
Journal:  Nutr J       Date:  2012-08-28       Impact factor: 3.271

Review 9.  Association between funding source, methodological quality and research outcomes in randomized controlled trials of synbiotics, probiotics and prebiotics added to infant formula: a systematic review.

Authors:  Mary N Mugambi; Alfred Musekiwa; Martani Lombard; Taryn Young; Reneé Blaauw
Journal:  BMC Med Res Methodol       Date:  2013-11-13       Impact factor: 4.615

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.